HCPCS code J1072 — Inj, testosterone, azmiro. Status: Active. Effective Apr 1, 2025. Source: CMS HCPCS Level II.

J1072

Active

Inj, testosterone, azmiro

Injection, testosterone cypionate (azmiro), 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2025
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 2069

MUE — Medically Unlikely Edits

Maximum units of J1072 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 400
Outpatient Hospital 400
Practitioner Services 400

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
24338-0055-01 Azmiro
24338-0056-01 Azmiro

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q2
    Inj, testosterone, azmiro